Novelix Pharmaceuticals Ltd vs Valiant Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Novelix Pharmaceuticals Ltd is ₹ 54 as of 05 May 15:30 . The P/E Ratio of Novelix Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Valiant Laboratories Ltd changed from 2080 on March 2024 to 0 on March 2025 . This represents a CAGR of -100.00% over 2 years The Market Cap of Novelix Pharmaceuticals Ltd changed from ₹ 5.48 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Valiant Laboratories Ltd changed from ₹ 632.63 crore on March 2024 to ₹ 333.65 crore on March 2025 . This represents a CAGR of -27.38% over 2 years The revenue of Novelix Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Valiant Laboratories Ltd for the Dec '25 is ₹ 53.09 crore as compare to the Sep '25 revenue of ₹ 47.07 crore. This represent the growth of 12.79% The ebitda of Novelix Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Valiant Laboratories Ltd for the Dec '25 is ₹ -0.26 crore as compare to the Sep '25 ebitda of ₹ 0.94 crore. This represent the decline of -127% The net profit of Novelix Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Valiant Laboratories Ltd changed from ₹ -0.51 crore to ₹ -7.06 crore over 7 quarters. This represents a CAGR of 348.88% The Dividend Payout of Novelix Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Valiant Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Novelix Pharmaceuticals Ltd

Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs & Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Company.
Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016. Initially, the company was engaged in finance and investments in securities.
They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company.
Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.

About Valiant Laboratories Ltd

Valiant Laboratories Limited was originally formed as a Partnership Firm as M/s.
Bharat Chemicals' through deed of partnership dated October 17, 1980.
The said Partnership Firm, M/s.
Bharat Chemicals thereafter converted into a Public Company to 'Valiant Laboratories Limited' via Certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies. The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol.
The Company gradually, commenced manufacturing of Paracetamol by late 1982.

FAQs for the comparison of Novelix Pharmaceuticals Ltd and Valiant Laboratories Ltd

Which company has a larger market capitalization, Novelix Pharmaceuticals Ltd or Valiant Laboratories Ltd?

Market cap of Novelix Pharmaceuticals Ltd is 58 Cr while Market cap of Valiant Laboratories Ltd is 437 Cr

What are the key factors driving the stock performance of Novelix Pharmaceuticals Ltd and Valiant Laboratories Ltd?

The stock performance of Novelix Pharmaceuticals Ltd and Valiant Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Novelix Pharmaceuticals Ltd and Valiant Laboratories Ltd?

As of May 5, 2026, the Novelix Pharmaceuticals Ltd stock price is INR ₹40.5. On the other hand, Valiant Laboratories Ltd stock price is INR ₹80.64.

How do dividend payouts of Novelix Pharmaceuticals Ltd and Valiant Laboratories Ltd compare?

To compare the dividend payouts of Novelix Pharmaceuticals Ltd and Valiant Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.